Aspire Biopharma Holdings Other Current Liabilities

Aspire Biopharma Holdings (ASBP) currently reports a other current liabilities of $710K as of June 2026. That compares with $730K in the prior-year period — down 2.4% year over year. Use the charts on this page to explore Aspire Biopharma Holdings's other current liabilities history and peer comparisons.

Aspire Biopharma Holdings's other current liabilities decreased from $730K to $710K — a 2.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $710K in other current liabilities as of June 2026. That compares with $730K in the prior-year period — down 2.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $710K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.